Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups

Cancer Cell

Volumn 27, Issue 5, 2015, Pages 728-743

  Pajtler, Kristian W ^a,b   Witt, Hendrik ^a,c   Sill, Martin ^a   Jones, David T W ^a   Hovestadt, Volker ^a   Kratochwil, Fabian ^a   Wani, Khalida ^d   Tatevossian, Ruth ^e   Punchihewa, Chandanamali ^e   Johann, Pascal ^a   Reimand, Jüri ^f   Warnatz, Hans Jörg ^g   Ryzhova, Marina ^h   Mack, Steve ⁱ   Ramaswamy, Vijay ⁱ   Capper, David ^a,j   Schweizer, Leonille ^a,j   Sieber, Laura ^a   Wittmann, Andrea ^a   Huang, Zhiqin ^a   van Sluis, Peter ^k   Volckmann, Richard ^k   Koster, Jan ^k   Versteeg, Rogier ^k   Fults, Daniel ^l   Toledano, Helen ^m   Avigad, Smadar ⁿ   Hoffman, Lindsey M ^o   Donson, Andrew M ^o   Foreman, Nicholas ^o   Hewer, Ekkehard ^p   Zitterbart, Karel ^q,r   Gilbert, Mark ^d   Armstrong, Terri S ^d,s   Gupta, Nalin ^t   Allen, Jeffrey C ^u   Karajannis, Matthias A ^u   Zagzag, David ^v   Hasselblatt, Martin ^w   Kulozik, Andreas E ^c   Witt, Olaf ^a,c   Collins, V Peter ^x   von Hoff, Katja ^y   Rutkowski, Stefan ^y   Pietsch, Torsten ^z   Bader, Gary ^f   Yaspo, Marie Laure ^g   von Deimling, Andreas ^a,j   Lichter, Peter ^a   Taylor, Michael D ⁱ   Gilbertson, Richard ^e   Ellison, David W ^e   Aldape, Kenneth ^aa   Korshunov, Andrey ^a,j   Kool, Marcel ^a   Pfister, Stefan M ^a,c   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^h BURDENKO NEUROSURGICAL INSTITUTE   (Russian Federation)

ⁱ HOSPITAL FOR SICK CHILDREN   (Canada)

^j UNIVERSITY OF HEIDELBERG   (Germany)

^k ACADEMIC MEDICAL CENTER   (Netherlands)

^l UNIVERSITY OF UTAH   (United States)

^m SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

ⁿ TEL AVIV UNIVERSITY   (Israel)

^o Nutrition Obesity Research Center at the University of Colorado   (United States)

^p UNIVERSITY OF BERN   (Switzerland)

^q UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^r MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^s UNIVERSITY OF TEXAS   (United States)

^t UNIVERSITY OF CALIFORNIA   (United States)

^u NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^v NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^w UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^x UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^y UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^z UNIVERSITY OF BONN   (Germany)

^aa UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR YAP1; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; YAP1 (YES-ASSOCIATED) PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN TUMOR; CANCER CLASSIFICATION; CANCER GRADING; CENTRAL NERVOUS SYSTEM; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DNA METHYLATION; EPENDYMOMA; FEMALE; FUSION GENE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR MECHANICS; POSTERIOR FOSSA; PRIORITY JOURNAL; SCHOOL CHILD; SPINE; WORLD HEALTH ORGANIZATION; AGE; CENTRAL NERVOUS SYSTEM TUMOR; CLASSIFICATION; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE FUSION; GENETIC TRANSCRIPTION; GENETICS; INFANT; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; AGE FACTORS; AGED; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; DNA METHYLATION; EPENDYMOMA; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE FUSION; HUMANS; INFANT; MALE; MIDDLE AGED; PHOSPHOPROTEINS; TRANSCRIPTION, GENETIC; YOUNG ADULT;

EID: 84929178049     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2015.04.002     Document Type: Article

References (52)

1. Archer T.C., Pomeroy S.L. Posterior fossa ependymomas: a tale of two subtypes. Cancer Cell 2011, 20:133-134.
2. Bouffet E., Foreman N. Chemotherapy for intracranial ependymomas. Childs Nerv. Syst. 1999, 15:563-570.
3. Bouffet E., Tabori U., Huang A., Bartels U. Ependymoma: lessons from the past, prospects for the future. Childs Nerv. Syst. 2009, 25:1383-1384. author reply 1385.
4. Brennan C.W., Verhaak R.G., McKenna A., Campos B., Noushmehr H., Salama S.R., Zheng S., Chakravarty D., Sanborn J.Z., Berman S.H., et al. The somatic genomic landscape of glioblastoma. Cell 2013, 155:462-477. TCGA Research Network.
5. Carter M., Nicholson J., Ross F., Crolla J., Allibone R., Balaji V., Perry R., Walker D., Gilbertson R., Ellison D.W. Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. Br. J. Cancer 2002, 86:929-939.
6. Dan H.C., Cooper M.J., Cogswell P.C., Duncan J.A., Ting J.P., Baldwin A.S. Akt-dependent regulation of NF-kappaB is controlled by mTOR and Raptor in association with IKK. Genes Dev. 2008, 22:1490-1500.
7. Dyer S., Prebble E., Davison V., Davies P., Ramani P., Ellison D., Grundy R. Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. Am. J. Pathol. 2002, 161:2133-2141.
8. Ebert C., von Haken M., Meyer-Puttlitz B., Wiestler O.D., Reifenberger G., Pietsch T., von Deimling A. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. Am. J. Pathol. 1999, 155:627-632.
9. Ellison D.W., Kocak M., Figarella-Branger D., Felice G., Catherine G., Pietsch T., Frappaz D., Massimino M., Grill J., Boyett J.M., Grundy R.G. Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. J. Negat. Results Biomed. 2011, 10:7.
10. Gajjar A., Pfister S.M., Taylor M.D., Gilbertson R.J. Molecular insights into pediatric brain tumors have the potential to transform therapy. Clin. Cancer Res. 2014, 20:5630-5640.
11. Gaspar N., Grill J., Geoerger B., Lellouch-Tubiana A., Michalowski M.B., Vassal G. p53 Pathway dysfunction in primary childhood ependymomas. Pediatr. Blood Cancer 2006, 46:604-613.
12. Gatta G., Botta L., Rossi S., Aareleid T., Bielska-Lasota M., Clavel J., Dimitrova N., Jakab Z., Kaatsch P., Lacour B., et al. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5-a population-based study. Lancet Oncol. 2014, 15:35-47. EUROCARE Working Group.
13. Godfraind C., Kaczmarska J.M., Kocak M., Dalton J., Wright K.D., Sanford R.A., Boop F.A., Gajjar A., Merchant T.E., Ellison D.W. Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas. Acta Neuropathol. 2012, 124:247-257.
14. Heinze G., Schemper M. A solution to the problem of monotone likelihood in Cox regression. Biometrics 2001, 57:114-119.
15. Hoadley K.A., Yau C., Wolf D.M., Cherniack A.D., Tamborero D., Ng S., Leiserson M.D., Niu B., McLellan M.D., Uzunangelov V., et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 2014, 158:929-944. Cancer Genome Atlas Research Network.
16. Hovestadt V., Remke M., Kool M., Pietsch T., Northcott P.A., Fischer R., Cavalli F.M., Ramaswamy V., Zapatka M., Reifenberger G., et al. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays. Acta Neuropathol. 2013, 125:913-916.
17. Hovestadt V., Jones D.T., Picelli S., Wang W., Kool M., Northcott P.A., Sultan M., Stachurski K., Ryzhova M., Warnatz H.J., et al. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing. Nature 2014, 510:537-541.
18. Johnson R.A., Wright K.D., Poppleton H., Mohankumar K.M., Finkelstein D., Pounds S.B., Rand V., Leary S.E., White E., Eden C., et al. Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 2010, 466:632-636.
19. Kilday J.P., Rahman R., Dyer S., Ridley L., Lowe J., Coyle B., Grundy R. Pediatric ependymoma: biological perspectives. Mol. Cancer Res. 2009, 7:765-786.
20. Kilday J.P., Mitra B., Domerg C., Ward J., Andreiuolo F., Osteso-Ibanez T., Mauguen A., Varlet P., Le Deley M.C., Lowe J., et al. Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP). Clin. Cancer Res. 2012, 18:2001-2011.
21. Kool M., Korshunov A., Remke M., Jones D.T., Schlanstein M., Northcott P.A., Cho Y.J., Koster J., Schouten-van Meeteren A., van Vuurden D., et al. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol. 2012, 123:473-484.
22. Korbel J.O., Campbell P.J. Criteria for inference of chromothripsis in cancer genomes. Cell 2013, 152:1226-1236.
23. Korshunov A., Witt H., Hielscher T., Benner A., Remke M., Ryzhova M., Milde T., Bender S., Wittmann A., Schöttler A., et al. Molecular staging of intracranial ependymoma in children and adults. J. Clin. Oncol. 2010, 28:3182-3190.
24. Kurian K.M., Jones D.T., Marsden F., Openshaw S.W., Pearson D.M., Ichimura K., Collins V.P. Genome-wide analysis of subependymomas shows underlying chromosomal copy number changes involving chromosomes 6, 7, 8 and 14 in a proportion of cases. Brain Pathol. 2008, 18:469-473.
25. Li Y., Fong K.W., Tang M., Han X., Gong Z., Ma W., Hebert M., Songyang Z., Chen J. Fam118B, a newly identified component of Cajal bodies, is required for Cajal body formation, snRNP biogenesis and cell viability. J. Cell Sci. 2014, 127:2029-2039.
26. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., Scheithauer B.W., Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007, 114:97-109.
27. Mack S.C., Witt H., Piro R.M., Gu L., Zuyderduyn S., Stütz A.M., Wang X., Gallo M., Garzia L., Zayne K., et al. Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature 2014, 506:445-450.
28. McGuire C.S., Sainani K.L., Fisher P.G. Both location and age predict survival in ependymoma: a SEER study. Pediatr. Blood Cancer 2009, 52:65-69.
29. Mendrzyk F., Korshunov A., Benner A., Toedt G., Pfister S., Radlwimmer B., Lichter P. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma. Clin. Cancer Res. 2006, 12:2070-2079.
30. Merchant T.E., Li C., Xiong X., Kun L.E., Boop F.A., Sanford R.A. Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol. 2009, 10:258-266.
31. Modena P., Buttarelli F.R., Miceli R., Piccinin E., Baldi C., Antonelli M., Morra I., Lauriola L., Di Rocco C., Garrè M.L., et al. Predictors of outcome in an AIEOP series of childhood ependymomas: a multifactorial analysis. Neuro-oncol. 2012, 14:1346-1356.
32. Northcott P.A., Jones D.T., Kool M., Robinson G.W., Gilbertson R.J., Cho Y.J., Pomeroy S.L., Korshunov A., Lichter P., Taylor M.D., Pfister S.M. Medulloblastomics: the end of the beginning. Nat. Rev. Cancer 2012, 12:818-834.
33. Ohgaki H., Eibl R.H., Schwab M., Reichel M.B., Mariani L., Gehring M., Petersen I., Höll T., Wiestler O.D., Kleihues P. Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Mol. Carcinog. 1993, 8:74-80.
34. Ostrom Q.T., Gittleman H., Liao P., Rouse C., Chen Y., Dowling J., Wolinsky Y., Kruchko C., Barnholtz-Sloan J. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro-oncol. 2014, 16(Suppl 4):iv1-iv63.
35. Parker M., Mohankumar K.M., Punchihewa C., Weinlich R., Dalton J.D., Li Y., Lee R., Tatevossian R.G., Phoenix T.N., Thiruvenkatam R., et al. C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma. Nature 2014, 506:451-455.
36. Ramaswamy V., Remke M., Bouffet E., Faria C.C., Perreault S., Cho Y.J., Shih D.J., Luu B., Dubuc A.M., Northcott P.A., et al. Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. Lancet Oncol. 2013, 14:1200-1207.
37. Rausch T., Jones D.T., Zapatka M., Stütz A.M., Zichner T., Weischenfeldt J., Jäger N., Remke M., Shih D., Northcott P.A., et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 2012, 148:59-71.
38. Reimand J., Arak T., Vilo J. g:Profiler-a web server for functional interpretation of gene lists (2011 update). Nucleic Acids Res. 2011, 39:W307-W315.
39. Rubio M.P., Correa K.M., Ramesh V., MacCollin M.M., Jacoby L.B., von Deimling A., Gusella J.F., Louis D.N. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res. 1994, 54:45-47.
40. Singh P.K., Gutmann D.H., Fuller C.E., Newsham I.F., Perry A. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas. Mod. Pathol. 2002, 15:526-531.
41. Slavc I., MacCollin M.M., Dunn M., Jones S., Sutton L., Gusella J.F., Biegel J.A. Exon scanning for mutations of the NF2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas. Int. J. Cancer 1995, 64:243-247.
42. Sturm D., Witt H., Hovestadt V., Khuong-Quang D.A., Jones D.T., Konermann C., Pfaff E., Tönjes M., Sill M., Bender S., et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 2012, 22:425-437.
43. Sturm D., Bender S., Jones D.T., Lichter P., Grill J., Becher O., Hawkins C., Majewski J., Jones C., Costello J.F., et al. Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nat. Rev. Cancer 2014, 14:92-107.
44. Taylor M.D., Poppleton H., Fuller C., Su X., Liu Y., Jensen P., Magdaleno S., Dalton J., Calabrese C., Board J., et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 2005, 8:323-335.
45. Taylor M.D., Northcott P.A., Korshunov A., Remke M., Cho Y.J., Clifford S.C., Eberhart C.G., Parsons D.W., Rutkowski S., Gajjar A., et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 2012, 123:465-472.
46. Tihan T., Zhou T., Holmes E., Burger P.C., Ozuysal S., Rushing E.J. The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factors. Mod. Pathol. 2008, 21:165-177.
47. Tremblay A.M., Missiaglia E., Galli G.G., Hettmer S., Urcia R., Carrara M., Judson R.N., Thway K., Nadal G., Selfe J.L., et al. The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation. Cancer Cell 2014, 26:273-287.
48. Valouev A., Weng Z., Sweeney R.T., Varma S., Le Q.T., Kong C., Sidow A., West R.B. Discovery of recurrent structural variants in nasopharyngeal carcinoma. Genome Res. 2014, 24:300-309.
49. Venkatramani R., Dhall G., Patel M., Grimm J., Hawkins C., McComb G., Krieger M., Wong K., O'Neil S., Finlay J.L. Supratentorial ependymoma in children: to observe or to treat following gross total resection?. Pediatr. Blood Cancer 2012, 58:380-383.
50. Wani K., Armstrong T.S., Vera-Bolanos E., Raghunathan A., Ellison D., Gilbertson R., Vaillant B., Goldman S., Packer R.J., Fouladi M., et al. A prognostic gene expression signature in infratentorial ependymoma. Acta Neuropathol. 2012, 123:727-738. Collaborative Ependymoma Research Network.
51. Witt H., Mack S.C., Ryzhova M., Bender S., Sill M., Isserlin R., Benner A., Hielscher T., Milde T., Remke M., et al. Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 2011, 20:143-157.
52. Wu L., Sun T., Kobayashi K., Gao P., Griffin J.D. Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors. Mol. Cell. Biol. 2002, 22:7688-7700.